{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:55Z","timestamp":1781089135010,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>To report a rare case of orbital mucosa-associated lymphoid tissue (MALT) lymphoma presenting in a relatively young adult with inferior rectus involvement, and to review the literature on this atypical presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 46-year-old man presented with progressive swelling of the right lower eyelid, proptosis, and restricted eye movement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Orbital magnetic resonance imaging revealed a well-defined, homogeneously enhancing mass involving the inferior rectus. Histopathology confirmed MALT lymphoma with immunophenotyping positive for CD20, BCL2, and myeloid cell nuclear differentiation antigen, and negative for CD5, CD10, and Cyclin D1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent orbital biopsy via the lamina papyracea, allowing safe access to the inferomedial orbit. He then received definitive radiotherapy (24 Gy in 16 fractions) following National Comprehensive Cancer Network guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient showed a good early metabolic response to orbital radiotherapy on post-treatment positron emission tomography, without significant acute adverse effects, and was scheduled for ongoing surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case illustrates an unusual demographic and anatomical presentation of orbital MALT lymphoma. The lamina papyracea route enabled high-quality tissue acquisition in a delicate periocular region, aiding accurate diagnosis. Literature review highlights the predominance of older female patients and superolateral orbital involvement, contrasting with this younger male case with inferior rectus infiltration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047240","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:27Z","timestamp":1769191347000},"page":"e47240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Atypical orbital mucosa-associated lymphoid tissue lymphoma involving the inferior rectus in a young adult: A case report and literature review"],"prefix":"10.1097","volume":"105","author":[{"given":"Yin-Feng","family":"Wang","sequence":"first","affiliation":[{"name":"Education Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forn-Chia","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsiang","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Min","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4378-1359","authenticated-orcid":false,"given":"Sheng-Chi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Department of Ophthalmology, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas.","volume":"403","author":"Silkenstedt","year":"2024","journal-title":"Lancet"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","article-title":"Orbital lymphoma.","volume":"64","author":"Olsen","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.survophthal.2019.06.006","article-title":"Diagnosis of orbital mass lesions: clinical, radiological, and pathological recommendations.","volume":"64","author":"Mombaerts","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"705","DOI":"10.18240\/ijo.2023.05.06","article-title":"Predicting the prognosis of primary orbital lymphoma by clinical characteristics and imaging features.","volume":"16","author":"Zhu","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"R6-20260610","first-page":"2144","article-title":"Orbital lymphoma: clinical features and management at Dr. M. Djamil General Hospital in 2018.","volume":"6","author":"Rahmi","year":"2022","journal-title":"Bioscientia Med: J Biomed Transl Res"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13244-012-0156-1","article-title":"Orbital lymphoma: imaging features and differential diagnosis.","volume":"3","author":"Priego","year":"2012","journal-title":"Insights Imaging"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3988\/jcn.2019.15.3.398","article-title":"Orbital lymphoma presenting with inferior rectus palsy.","volume":"15","author":"Jung","year":"2019","journal-title":"J Clin Neurol"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3988\/jcn.2020.16.4.711","article-title":"Inferior divisional oculomotor nerve palsy due to orbital lymphoma.","volume":"16","author":"Lee","year":"2020","journal-title":"J Clin Neurol"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/IOP.0000000000001426","article-title":"Clinicopathological features and outcomes in lymphoma of extraocular muscles.","volume":"35","author":"Eade","year":"2019","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2008.09.011","article-title":"Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.","volume":"90","author":"Nam","year":"2009","journal-title":"Radiother Oncol"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/aol-20-14","article-title":"Pathology of extranodal marginal zone lymphoma at different anatomic sites.","volume":"4","author":"Wotherspoon","year":"2020","journal-title":"Ann Lymphoma"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13000-024-01481-6","article-title":"MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.","volume":"19","author":"Zhang","year":"2024","journal-title":"Diagn Pathol"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ajcp\/105.1.31","article-title":"CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.","volume":"105","author":"Ferry","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"270","DOI":"10.12998\/wjcc.v3.i3.270","article-title":"Endoscopic treatment of orbital tumors.","volume":"3","author":"Signorelli","year":"2015","journal-title":"World J Clin Cases"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.3390\/ijms23158609","article-title":"Evaluation of orbital lymphoproliferative and inflammatory disorders by gene expression analysis.","volume":"23","author":"Al-Ghazzawi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/CCO.0000000000000886","article-title":"Bacterial infection-driven lymphomagenesis.","volume":"34","author":"Vannata","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"3","DOI":"10.12701\/yujm.2021.01263","article-title":"Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review.","volume":"39","author":"Chung","year":"2022","journal-title":"J Yeungnam Med Sci"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s10067-024-06966-9","article-title":"Combination of Sj\u00f6gren\u2019s syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature.","volume":"43","author":"Golovina","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-11-0165","article-title":"Prediagnostic serum levels of cytokines and other immune markers and risk of non-Hodgkin lymphoma.","volume":"71","author":"Purdue","year":"2011","journal-title":"Cancer Res"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.7150\/jca.95339","article-title":"GNL3L exhibits pro-tumor activities via NF-\u03baB pathway as a poor prognostic factor in acute myeloid leukemia.","volume":"15","author":"Li","year":"2024","journal-title":"J Cancer"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12672-025-02811-w","article-title":"Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer.","volume":"16","author":"Chen","year":"2025","journal-title":"Discov Oncol"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"e71317","DOI":"10.1002\/cam4.71317","article-title":"Metabolic reprogramming in lung cancer: hallmarks, mechanisms, and targeted strategies to overcome immune resistance.","volume":"14","author":"Chen","year":"2025","journal-title":"Cancer Med"},{"key":"R25-20260610","article-title":"Bibliometric analysis of immune-related acute kidney injury induced by cancer immunotherapy (2000-2025) [published online ahead of print September 8, 2025].","author":"Zhang","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R26-20260610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.55940\/medphar202567","article-title":"MDM2 antagonists and p53-targeting therapies in cancer: clinical applications, adverse effects, and resistance mechanisms.","volume":"4","author":"Almukram","year":"2025","journal-title":"Med Pharm J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:02:57Z","timestamp":1781085777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047240","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-09-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}